Target intelligence / Profile preview

RNA, 7SK small nuclear pseudogene 282 (RN7SKP282)

Target
RN7SKP282
Molecular classification
Other (classified as small nuclear RNA pseudogene)
01

Overview

RN7SK pseudogene 282 (RN7SKP282) is a pseudogene related to RN7SK, a well-studied small nuclear RNA involved in transcription elongation and immune regulation, especially in macrophage polarization and phagocytosis[2][3]. However, unlike the functional RN7SK transcript, RN7SKP282 is classified as a non-protein-coding RNA pseudogene without validated biological function, disease relevance, or evidence as a direct molecular drug target. All known molecular functions and disease roles relate to the canonical RN7SK, not its pseudogenes. Consequently, RN7SKP282 is not considered a therapeutic target, and many relevant fields (molecular classification, disease roles, drug interactions, biomarkers, safety concerns) should be labeled as null or omitted for this entity[1][2][3]. If you are seeking details for the functional RN7SK molecule itself, refer specifically to "RNA, 7SK small nuclear RNA" (RN7SK), which acts as a long non-coding RNA modulating transcriptional elongation and immune cell function[2][3]. RN7SKP282 shares sequence similarity but lacks the evidence for functional activity.

Other names
RN7SKP282RNA, 7SK small nuclear pseudogene 282

Beyond the preview

Go deeper on RNA, 7SK small nuclear pseudogene 282 (RN7SKP282).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SK small nuclear pseudogene 282 (RN7SKP282).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call